Anteo Diagnostics Limited (ADO) announced that the Japanese Patent Office has granted the “Use of Metal Complexes” patent for Mix&GoTM. It is unusual that patents are granted in Japan as quickly as this. Its granting provides Anteo with further confidence in the quality of the science and security over the intellectual property (IP) in a commercially large jurisdiction.
There are many commercially important reasons to bind biological molecules onto synthetic materials. These molecules are often fragile and do not react well when exposed to non-biological conditions. Mix&GoTM has been demonstrated to allow them to retain their activity when bound. The “Use of Metal Complexes” patent covers the IP for the use of Mix&GoTM to facilitate this important binding process. Anteo has demonstrated that the benefits of Mix&GoTM over existing methods are both numerous and significant from technical and commercial perspectives. Further, the Mix&GoTM technology has broad applications in non-biological markets. This is another important patent to be granted to Anteo in a key market and marks another critical step in the continued effort to strengthen the IP of the Mix&GoTM technology.
Anteo’s Chief Executive Officer Dr. Geoff Cumming commented “Anteo is extremely pleased to be granted the “Use of Metal Complexes” patent. In particular we were pleased with the outcome given the relative difficulty of achieving such grants in Japan. “As we continue to advance negotiations for new licensing agreements, protecting the Mix&GoTM technology is of critical importance for Anteo.” Anteo is also pleased to inform shareholders that the company has progressed dialogue with potential customers in recent months. As previously explained, these negotiations take a significant amount of time due to the due diligence considered necessary by interested parties before incorporating Mix&GoTM into their commercial products.”



